Hyponatremia after administration of conditioning regimen in myelodysplastic syndrome with empty sella after glandula pituitaria surgery [1]

Annals of Hematology

Volumn 86, Issue 11, 2007, Pages 843-844

  Tsutsumi, Yutaka ^a   Shiratori, Souichi ^a   Nakata, Asako ^a   Kawamura, Takahito ^a   Mashiko, Shinobu ^a   Ibata, Makoto ^a   Mori, Akio ^a   Tanaka, Junji ^b   Asaka, Masahiro ^b   Imamura, Masahiro ^b   Masauzi, Nobuo ^a  

^a Hakodate Municipal Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYTARABINE; FLUDARABINE; MINOCYCLINE; SODIUM; SODIUM CHLORIDE; VASOPRESSIN;

ADULT; CANCER REGRESSION; CASE REPORT; EMPTY SELLA SYNDROME; ENDOCRINE SURGERY; FATIGUE; FEMALE; HLA MATCHING; HUMAN; HYPONATREMIA; HYPOPHYSIS ADENOMA; IMMUNOSUPPRESSIVE TREATMENT; INAPPROPRIATE VASOPRESSIN SECRETION; LETTER; LOW DRUG DOSE; MYELODYSPLASTIC SYNDROME; NEUROHYPOPHYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA OSMOLARITY; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; SODIUM BLOOD LEVEL; STEM CELL TRANSPLANTATION; URINE OSMOLALITY; WHOLE BODY RADIATION;

ADENOMA; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BUSULFAN; FEMALE; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; MIDDLE AGED; PITUITARY GLAND, POSTERIOR; PITUITARY NEOPLASMS; TRANSPLANTATION CONDITIONING;

EID: 34848908791     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0291-9     Document Type: Letter

References (8)

1. Milionis HJ, Liamis GL, Elisaf MS (2002) The hyponatremic patient: A systematic approach to laboratory diagnosis. JAMC 166:1056-1062
2. Slater LM, Wainer RA, Serpick AA (1969) Vincristine neurotoxity with hyponatremia. Cancer 23:122-125
3. Harlow PJ, DeClerck YA, Shore NA, Carranza A, Heuser E (1979) A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer 44:896-898
4. Sorensen JB, Anderson MK, Hansen HH (1995) Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 238:97-110
5. Kobayashi R, Iguchi A, Nakajima M, Sato T, Yoshida M, Kaneda M, Suzuki Y, Mino E, Kuroki F, Kobayashi K (2004) Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation. Bone Marrow Transplant 34:975-979
6. Vassal G, Deroussent A, Hartmann O, Chaline D, Benhamou E, Valteau-Couanet D, Brugieres L, Kalifa C, Gouyette A, Lemerle J (1990) Dose-dependent neurotoxicity of high-dose busulfan in children: A clinical and pharmacological study. Cancer Res 50:6203-6207
7. Elliott MA, Letendre L, Li CY, Hoyer JD, Hammack JE (1999) Chronic lymphocytic leukemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine. Br J Haematol 104:689-694
8. Knop S, Herrlinger U, Ernemann U, Kanz L, Herbart H (2005) Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia. Leuk Lymphoma 46:1593-1598